Decitabine Market

Decitabine is also known as 5 - nitrogen hetero - 2 '- DNA cytosine nucleoside, 5 - n - 2' - deoxy cytidine acid, is a kind of natural 2 '- deoxy cytidine acid adenosine analogues, by inhibiting the DNA methyltransferase, reduce DNA methylation, thus inhibiting tumor cell proliferation, and prevent the occurrence of drug resistance, for the strongest known DNA methylation specific inhibitor, belongs to the S phase of cell cycle specific drugs, is suitable for the treatment of myelodysplastic syndrome (MDS).

Decitabine Market contains market size and forecasts of Decitabine in global, including the following market information:

Global Decitabine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Decitabine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Decitabine companies in 2021 (%)

The global Decitabine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10 Mg Dosage Forms Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Decitabine include Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, Sandoz, Dr Reddy's Laboratories, Accord Healthcare, Sun Pharmaceutical and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Decitabine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Decitabine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Decitabine Market Segment Percentages, by Type, 2021 (%)

10 Mg Dosage Forms

15 Mg Dosage Forms

25 Mg Dosage Forms

Global Decitabine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Decitabine Market Segment Percentages, by Application, 2021 (%)

Primary MDS

Secondary MDS

Global Decitabine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Decitabine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Decitabine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Decitabine revenues share in global market, 2021 (%)

Key companies Decitabine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Decitabine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Johnson & Johnson

Eli Lilly and Company

Pharmachemie B.V.

Otsuka Pharmaceutical

Sandoz

Dr Reddy's Laboratories

Accord Healthcare

Sun Pharmaceutical

Cipla

Lupin

Shandong Xinshidai Pharmaceutical

Hangzhou Zhongmei Huadong Pharmaceutical

ZHENGDA Tianqing Pharmaceutical Group

Jiangsu Aosaikang Pharmaceutical

Jiangsu Haosen Pharmaceutical Group

Lianyungang Jierui Pharmaceutical

Qilu Pharmaceutical Hainan

Lianyungang Runzhong Pharmaceutical